Bioquell plc Stock Price, News & Analysis (LON:BQE)

GBX 256.60 -1.90 (-0.74 %)
(As of 11/20/2017 04:00 PM ET)
Previous CloseGBX 256.60
Today's RangeGBX 256.60 - GBX 256.55
52-Week RangeGBX 127.12 - GBX 275
Volume4,153 shs
Average Volume23,887 shs
Market Capitalization£55.62 million
P/E RatioN/A
Dividend YieldN/A

About Bioquell plc (LON:BQE)

Bioquell plc logoBioquell Plc is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company's operating segment is Bio-decontamination (BIO). The Company offers various products, which include Healthcare products, such as Healthcare HP Vapor Services, Healthcare HP Vapor Generators, Healthcare Patient Rooms, Healthcare Pharmacy Workstation, Healthcare Consumables/Accessories and Healthcare Archived Products; Life Science products, such as Life Sciences Aseptic Workstation, Life Sciences HP Vapor Services, Life Sciences Materials Transfer, Life Sciences HP Vapor Generators, Life Sciences Consumables/Accessories and Archived Products, and Defense products, such as Defense CBRN Filtration, Controls, Defense Pre-filtration, and Defense Consumables and Spares.

Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Medical Equipment, Supplies & Distribution - NEC
  • Symbol: LON:BQE
  • CUSIP: N/A
  • Web:
  • Trailing EPS: GBX 0.05
  • Net Margins: 8.54%
  • Return on Equity: 9.99%
  • Return on Assets: 7.80%
  • Outstanding Shares: 22,450,000

Frequently Asked Questions for Bioquell plc (LON:BQE)

What is Bioquell plc's stock symbol?

Bioquell plc trades on the London Stock Exchange (LON) under the ticker symbol "BQE."

Who are some of Bioquell plc's key competitors?

Who are Bioquell plc's key executives?

Bioquell plc's management team includes the folowing people:

  • Nicholas M. T. Adams, Chief Executive, Executive Director
  • Michael R. D. Roller, Group Finance Director, Executive Director (Age 49)
  • Georgina Pope, Company Secretary
  • Ian Roy Johnson, Non-Executive Chairman of the Board (Age 63)
  • Ian Carruthers OBE, Independent Non-Executive Director
  • Simon John Constantine, Independent Non-Executive Director (Age 55)
  • Christopher Harwood Bernard Mills, Independent Non-Executive Director (Age 64)

How do I buy Bioquell plc stock?

Shares of Bioquell plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Bioquell plc's stock price today?

One share of Bioquell plc stock can currently be purchased for approximately GBX 256.60.

How big of a company is Bioquell plc?

Bioquell plc has a market capitalization of £55.62 million.

How can I contact Bioquell plc?

Bioquell plc's mailing address is West Portway, 52 Royce Close, ANDOVER, SP10 3TS, United Kingdom. The company can be reached via phone at +44-1264-835900.

MarketBeat Community Rating for Bioquell plc (LON BQE)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  142
MarketBeat's community ratings are surveys of what our community members think about Bioquell plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Bioquell plc (LON:BQE)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Bioquell plc (LON:BQE)

Price Target History for Bioquell plc (LON:BQE)

Analysts' Ratings History for Bioquell plc (LON:BQE)

DateFirmActionRatingPrice TargetDetails
3/7/2017N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 11/20/2015 forward)


Earnings History for Bioquell plc (LON:BQE)

No earnings announcements for this company have been tracked by


Earnings Estimates for Bioquell plc (LON:BQE)

No earnings estimates for this company have been tracked by


Dividend History by Quarter for Bioquell plc (LON BQE)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/18/2015GBX 3.302.8%6/4/20156/4/20157/2/2015
3/18/2014GBX 3.302.54%6/4/20146/4/20147/2/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bioquell plc (LON BQE)

Insider Trades by Quarter for Bioquell plc (LON:BQE)

Insider Trades by Quarter for Bioquell plc (LON BQE)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2017Georgina PopeInsiderSell2,500GBX 260£6,500
5/17/2017Michael R D RollerInsiderBuy13,381GBX 159£21,275.79
4/5/2017Michael R D RollerInsiderBuy19,000GBX 148£28,120
6/21/2016Mills,ChristopherInsiderSell6,305,000GBX 200£12,610,000
(Data available from 1/1/2013 forward)


Latest Headlines for Bioquell plc (LON BQE)


Social Media

Social activity is not available for this stock.


Financials are not available for this stock.


Bioquell plc (LON BQE) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.